Global Helicobacter Pylori Testing Market Outlook 2031:
The global helicobacter pylori testing market size was valued at USD 609 Million in 2022 and is projected to reach USD 859.32 Million by 2031, expanding at a CAGR of 3.9% during the forecast period 2023 - 2031. Helicobacter pylori also known as H. pylori is a bacterial infection which mainly affects patients suffering from gastric and duodenal ulcers.
Helicobacter pylori was categorized as a carcinogen (cancer causing agent) in 1994 by the international agency for research on cancer. Helicobacter pylori is a spiral shaped gram negative aerobic bacterium which commonly resides in the stomach and is responsible for balancing stomach ecology.
H. pylori infect the inner thin walls of the stomach which leads to inflammation in the walls of the stomach and duodenum. Almost 80% of people affected with ulcer are also infected with H. pylori. If this is left untreated for a long time can lead to stomach cancer. The H. pylori infection is mainly caused by consuming contaminated water or food containing faecal matter. About half of the world’s population may be infected with H. pylori bacteria but only 10% experience any problem.
Helicobacter Pylori Testing Market Trends, Drivers, Restraints, and Opportunities
- Factors such as increased awareness about the H. pylori, government measures for accurate diagnostics, new product release & advanced technologies, and FDA approvals are projected to drive the helicobacter pylori (H. Pylori) market.
- Increasing demand for personalized antibiotic therapy and improved cost-effectiveness of diagnosis are estimated to fuel the market.
- Easy accessibility and affordability of antibiotics along with short treatment durations will further boost the demand for pre and post monitoring tests.
- Precautionary measures and the fact that H. pylori mostly detected in youngsters and the elderly may hamper the market.
- Specialized and efficient infection diagnosis, along with rising awareness regarding infectious diseases is the key factors responsible for the market growth.
Scope of Helicobacter Pylori Testing Market Report
The report on the global H. pylori testing market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Helicobacter Pylori Testing Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016 & 2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Test Type (Serology Tests, Stool Antigen Test (SAT), and Urea Breath Test (UBT)), End Use (Hospitals, Diagnostic Laboratories, and Clinics) Technology (Immunoassay, Point of Care (POC), and Molecular Diagnostics)
|
|
Regional Scope
|
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa
|
|
Report Coverage
|
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast
|
|
Key Players Covered in the Report
|
Thermo Fisher Scientific, Quest Diagnostics Incorporate, and Meridian Bioscience.
|
Helicobacter Pylori Testing Market Segment Insights:
In terms of technology, the global H. pylori market is segmented into immunoassay, POC, and molecular diagnostics. The immunoassay segment holds the major market share. The immunoassay test is a biochemical test which measures the concentration or presence of a macromolecule in a solution with the help of an antibody or an antigen.
Due to the presence of several advanced technologies such as the enzyme immunoassays which is used for the detection of antibodies, the immunoassay is quite popular in diagnosis and holds a large share in the global helicobacter pylori testing market.
In terms of end use, the H. pylori market is fragmented into hospitals, diagnostics laboratories, and clinics. The diagnostic laboratories segment is expected to grow at a rapid pace during the forecast period. Factors such as the rising number of healthcare facilities and medical laboratories worldwide are driving the market.
Based on test types, the H. pylori market is segmented into serology test, urea breath test, and stool antigen test. The stool antigen test (SAT) segment is expected to hold a substantial market share. Factors such as accurate and efficient results by stool antigen test are driving the market.
In terms of regions, the global H. pylori market can be split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds a significant market share and is estimated to dominate the market during forecast period due to increasing prevalence of helicobacter pylori infections and rising awareness.
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) about 50% of people above the age of 60 and about 20% of people below the age of 40 have contracted H. pylori. Middle East & Africa holds almost equal percentage of share as compared to North America and is expected to hold a major market share in the coming future.
Segments
Technology
- Immunoassay
- POC
- Molecular diagnostics
End-use
- Hospitals
- Clinics
- Diagnostics laboratories
Test Types
- Serology test
- Urea breath test (UBT)
- Stool antigen test (SAT)
Region
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Key Players
Competitive Landscape
Key players in the H. pylori market include Thermo Fisher Scientific, Quest Diagnostics Incorporate, and Meridian Bioscience. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.
Request For Customization
Enquiry Before Buying
Speak With Analyst
